20 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicillium marneffei Infections ... Treating Acute Infection ... Penicilliosis #IDSA ... #HIVAIDS #pharmacology
Infections in Immunocompromised Patients - Differential Diagnosis Summary
Innate Immunity:
 • Neutropenia
 • Phagocytic Deficiencies
 • Complement
Infections in Immunocompromised ... Patients - Differential ... Immunocompromised #Infections ... #differential # ... diagnosis #infectiousdiseases
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
define the type of infection ... , then review prior ... #management #infectiousdisease ... #antibiogram #pharmacology
Daptomycin  - Antibiotics Class Overview

Mechanism: Lipopeptide antibiotic – forms transmembrane channels and depolarizes cells.
and depolarizes cells ... skin/soft tissue infections ... cidal nature) #Pharmacology ... #Antibiotics #Review
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Infection in HIV-AIDS ... Infection General ... #IDSA #Prevention ... #HIVAIDS #pharmacology
Blood Culture-Negative Infective Endocarditis (BCNIE)
Definition: No etiology found after 3 separate blood cultures remain negative for
Infection with ... special media) • Infection ... Work-up of BCNIE relies ... Endocarditis #diagnosis #differential ... #workup #infectiousdiseases
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
HIV / AIDS - Differential ... less than 200 cells ... more than 200 cells ... #differential # ... opportunistic #InfectiousDiseases
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... CD4 count <200 cells ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... Treating Mild Infections ... CD4 count <250 cells ... Coccidiodomycosis #IDSA ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... Cytomegalovirus Infections ... CD4 count >100 cells ... Cytomegalovirus #CMV #IDSA ... #HIVAIDS #pharmacology